一种基于免疫信息学的多疫苗提供了抗体介导的保护,防止Acinetobacter baumannii感染
Sean Jeffreys1, Jadelynn Aki1, Megan P Tompkins1
1Department of Molecular Microbiology and Immunology, University of Texas at San Antonio, San Antonio, TX 78249, USA.
Vaccines
|April 23, 2025
概括
这项研究揭示了Acinetobacter多位疫苗 (AMEV2) 如何保护抗多药耐药的Acinetobacter baumannii. 抗体通过 fagocytosis 增强杀死细菌,突出 AMEV2 的作用.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
背景情况:
- 宝曼尼菌 (Acinetobacter baumannii) 是一种多药耐药 (MDR) 病原体,导致严重的死亡率和医疗保健成本.
- 一种免疫信息学设计的候选疫苗AMEV2之前显示对MDR A. baumannii. baumannii. 的保护.
研究的目的:
- 阐明 AMEV2 中介保护的基础免疫机制.
- 评估抗体介导免疫在AMEV2疗效中的作用.
主要方法:
- 在小鼠模型中使用AMEV2抗菌素被动免疫.
- 在实验室中使用巨细胞进行子菌细胞杀死试验 (OPKAs).
- 针对特定疫苗成分的抗体消耗测定.
主要成果:
- 通过被动转移AMEV2抗血清,对A. baumannii肺部挑战进行了67%的保护.
- AMEV2抗体通过补充和Fc马受体介导的细胞酶增强了细菌清除.
- 一个关键的,pTonB,引起保护性抗体,其耗尽降低了疫苗的疗效.
结论:
- 幽默免疫和抗体介导的细胞分裂对于AMEV2的保护作用至关重要.
- 在基设计的疫苗提供了对全球MDR病原体威胁的有希望的策略.
更多相关视频
08:09Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
Published on: March 24, 2017
9.3K
11:07Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
Published on: April 29, 2015
13.2K
相关概念视频
01:51Vaccinations
43.0K
Overview
43.0K
01:23Immunological Memory
412
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
412
00:42Cross-reactivity
30.9K
Overview
30.9K
01:31Hybridoma Technology
13.8K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.8K
01:30Cancer Vaccines
238
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
238